About Us

Who We Are

Vascular Dynamics, based in Mountain View, California, is a private medical device company developing catheter-delivered technologies to bring a better quality of life to patients who are resistant to conventional treatments for hypertension. The company’s implantable MobiusHD® System was awarded CE Mark certification in December 2015. In the United States, the company was one of the nine companies chosen in 2012 by the U.S. Food and Drug Administration (FDA) to participate in the Early Feasibility Study Investigational Device Exemption (IDE) Pilot Program for the company’s MobiusHD implant.

Vascular Dynamics is conducting clinical trials in the United States and Europe to evaluate the safety and performance of the MobiusHD device.

Management Team

Ed Roschak

Ed Roschak

President & CEO, Vascular Dynamics

Mr. Roschak joins VDI from NuVasive Specialized Orthopedics, where he served as CEO upon the successful acquisition of his previous company, Ellipse Technologies, Inc., where he was president and CEO. Prior to his seven years at Ellipse, he held a variety of positions at Broncus Technologies, Inc., an interventional pulmonology startup company focused on asthma and emphysema. Asthmatx, Inc. was spun-out of Broncus and acquired by Boston Scientific. He also held engineering roles with increasing responsibility at Hewlett-Packard, Origin Medsystems and Krebs Engineers. Mr. Roschak is a named inventor on 30 granted patents, more than 60 patent applications published in the U.S., and more worldwide. He has also been published in the Journal of Thoracic Surgery. Mr. Roschak earned his MBA from the University of Oregon Executive Program and earned a BS in mechanical engineering from University of California, Santa Barbara.

Brent Seybold

Brent Seybold

Vice President, Technical Operations

Brent has extensive experience helping to transform medical devices from concepts to commercially viable products. He has served in senior technical roles at companies of various sizes including LuMend (Coronary/Peripheral CTO), Parallax Medical (Vertebroplasty), Genesis Medical Interventional (Coronary/ Peripheral Thrombectomy & Embolic Protection) and Micrus Endovascular (Ischemic Stroke). He joined the VDI team in 2011 and has been involved in R&D, Operations, clinical case support and physician training. Brent has a Bachelor of Science in Mechanical Engineering from the University of California, Davis.

Sujith Shetty

Sujith Shetty

Vice President, Clinical, Regulatory & Quality

Suji has served as vice president of Clinical, Regulatory, and Quality for Vascular Dynamics since March 2012. Prior to joining Vascular Dynamics he served as senior project manager, Clinical of Micrus Endovascular (MEND), which was acquired by Johnson and Johnson in 2010. Prior to Micrus, Suji was part of the clinical team at Pulmonx and Asthmatx, both companies with novel technology for lung conditions. Suji started his clinical research career as a research fellow at University of Southern California, where he participated in studies in Pulmonary and Critical Care and Cardiology. Suji received an M.B.B.S from Kempe Gowda Institute of Medical Science (Bangalore, India).

Board of Directors

Ed Roschak

Ed Roschak

President & CEO, Vascular Dynamics

Mr. Roschak joins VDI from NuVasive Specialized Orthopedics, where he served as CEO upon the successful acquisition of his previous company, Ellipse Technologies, Inc., where he was president and CEO. Prior to his seven years at Ellipse, he held a variety of positions at Broncus Technologies, Inc., an interventional pulmonology startup company focused on asthma and emphysema. Asthmatx, Inc. was spun-out of Broncus and acquired by Boston Scientific. He also held engineering roles with increasing responsibility at Hewlett-Packard, Origin Medsystems and Krebs Engineers. Mr. Roschak is a named inventor on 30 granted patents, more than 60 patent applications published in the U.S., and more worldwide. He has also been published in the Journal of Thoracic Surgery. Mr. Roschak earned his MBA from the University of Oregon Executive Program and earned a BS in mechanical engineering from University of California, Santa Barbara.

Dr. Thomas Thaler

Dr. Thomas Thaler

Board Member, Investment Advisor HBM Partners AG

Dr. Thaler has more than 15 years of experience in investment management and financial research. He is a former senior equity analyst at Bank Julius Baer covering medical technology and healthcare service companies. He also has 15 years of experience in the biotech and medical technology industry holding senior management positions with Sulzer Medica, Schneider (Europe) and Boston Scientific. Dr. Thaler holds a MSc from the Swiss Federal Institute of Technology, (ETH) Zurich in Biochemistry, a PhD in life sciences and a Masters degree in Business Administration (ETH/BWI). Dr. Thaler is a board member of Vascular Dynamics, Ellipse Technologies, Interventional Spine, MiCardia, Tensys Medical and ValCare Medical.

Efi Cohen-Arazi

Efi Cohen-Arazi

Board Member, CEO Rainbow Medical

Mr. Cohen-Arazi has more than 25 years of experience in the medical and biotech industries involving executive management responsibility for both development manufacturing and business. Prior to co-founding Rainbow Medical, Mr. Cohen-Arazi served as CEO of IntecPharma, Israel, a company specializing in drug development and delivery. Previously, Mr. Cohen-Arazi was vice president of Corporate Manufacturing, Head of Contract Manufacturing and Site Head at U.S.-based Amgen Corporation. Mr. Cohen-Arazi held senior positions at Immunex in the U.S. and at the Merck-Serono Group in Switzerland. Mr. Cohen-Arazi holds advanced life sciences degrees from the Hebrew University of Jerusalem.

Ben Tsai

Ben Tsai

Board Member, Partner at Invus Opportunities

Mr. Tsai is currently a partner at Invus Opportunities. Previously, Mr. Tsai was a consultant of the Monitor Group. He holds an MBA degree from Harvard Business School and a BS degree in Business Administration from the University of Southern California.

Michael Henson

Michael Henson

Chairman

Mr. Henson has founded or served as CEO and chairman/board member for 18 emerging healthcare (medical device or biotechnology) firms. Seven of these were privately held firms acquired by multinational companies, while six have advanced through the initial public offering (IPO) stage. Ten of the firms founded by Mr. Henson have been acquired by major healthcare firms. Several of these companies remain closely held private firms. In total, these firms have received financial investments of approximately $1 billion and have employed in excess of 1,000 people. Mr. Henson also serves as a principal manager for four private investment funds and as an advisor to two additional private investment funds, all focused on early and mid – stage medical device startup ventures.

Gerhard “Gary” Burbach

Gerhard “Gary” Burbach

Director

Mr. Burbach currently serves on the board of directors at Vascular Dynamics.

Mr. Burbach has extensive experience in the medical technology industry. Prior to joining VDI, he served as CEO of Thoratec Corporation, a publicly-traded company that develops, manufactures and markets proprietary medical devices used for circulatory support. He has also served in executive roles at Digirad Corporation, where he also served on the board, Bacchus Vascular, Inc., a developer of catheter-based medical devices and Philips Nuclear Medicine, a division of Philips Electronics, which had also acquired ADAC Laboratories, where he served as president. He also serves on several boards of directors, including Fluidigm, Inc., Procyrion and Autonomic Technologies.

Prior to his in-house management roles, Mr. Burbach spent six years with the management consulting firm of McKinsey & Company, Inc., where he was a senior engagement manager in the firm’s healthcare practice.

Mr. Burbach has a B.S. in Industrial Engineering from Stanford University and an M.B.A. from Harvard Business School.

Are you a Healthcare Professional outside of the U.S.?

 

The following page contains content about Vascular Dynamics products, which are only available for healthcare professionals outside of the United States. This content is NOT intended for U.S. audiences. Do you wish to continue?

No Yes

Caution: In the United States, the MobiusHD® system is limited by law to investigational use only.

You have Successfully Subscribed!

Are you a Patient outside of the U.S.?

 

The following page contains content about Vascular Dynamics products, which are only available for patients outside of the United States. This content is NOT intended for U.S. audiences. Do you wish to continue?

No Yes

You have Successfully Subscribed!

Are you a Healthcare Professional in the U.S.?

 

The following page contains content about Vascular Dynamics products, which are only available for healthcare professionals in the United States. This content is ONLY intended for U.S. audiences. Do you wish to continue?

No Yes

Caution: In the United States, the MobiusHD® system is limited by law to investigational use only.

You have Successfully Subscribed!

Are you a Patient in the U.S.?

 

The following page contains content about Vascular Dynamics products, which are not available for marketing in the United States. This content is ONLY intended for U.S. audiences. Do you wish to continue?

No Yes

You have Successfully Subscribed!

Are you a Patient outside of the U.S.?

 

The following page contains content about Vascular Dynamics products, which are only available for patients outside of the United States. This content is NOT intended for U.S. audiences. Do you wish to continue?

No Yes

You have Successfully Subscribed!

Are you a Patient in the U.S.?

 

The following page contains content about Vascular Dynamics products, which are not available for marketing in the United States. This content is ONLY intended for U.S. audiences. Do you wish to continue?

No Yes

You have Successfully Subscribed!

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

MobiusHD®Procedure

You have Successfully Subscribed!